Showcasing our AI-powered digital cytotoxicity and cell viability assay, we demonstrate how Nanolive’s high-content live cell imaging can be used to increase confidence in lead candidate selection.
In this webinar, we explore the following drug discovery applications of Nanolive’s LIVE Cell Death Assay – all completely label-free:
Cell Death
- Drug screening in a 96-well plate
- Differentiating between necrotic and apoptotic cell death
- Detecting therapy resistance
Cell Health, Stress and Recovery
- Detecting cell stress before death
- Investigating therapy resistance using the Health Cell Index and Refractive Index imaging
- Monitoring cell recovery from the apoptotic pathway (anastasis)

Speaker: Hope Amos
Scientific Communication Specialist
Read our latest news
Simplifying drug delivery assessment: Industry perspectives
Optimization of drug delivery systems can become slow, resource intensive, and reliant on incomplete information. With one assay, Nanolive monitors the complete dynamics of drug delivery, reducing phototoxicity from labels and helping teams identify where delivery succeeds or fails.
Webinar – Investigating nanoparticle delivery with label-free live cell imaging
Watch our latest webinar, where Elizabeth Nelson shares research performed at the MIT Koch Institute for Integrative Cancer Research, demonstrating a live-cell imaging workflow to quantify the dynamic uptake of nanoparticles…
Move beyond endpoints with dynamic EC50
Discover case study data for a dynamic approach to monitoring EC50 to gain more accurate insights into drug function.

